Skip to main content
OpenTrials

Clinical trial condition

Relapsed/Refractory Immune Thrombocytopenia

Explore clinical trials studying Relapsed/Refractory Immune Thrombocytopenia. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Relapsed/Refractory Immune Thrombocytopenia trial results

Recruiting

The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia

NCT05599880

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Seoul National University Bundang Hospital Guri-si, South Korea
  • Seoul National University Hospital Seoul, South Korea
  • SMG-SNU Boramae Medical Center Seoul, South Korea
  • Seoul National University Hospital Seoul, South Korea
View Trial Details

Related conditions